- €899.08m
- €1.46bn
- €1.28bn
Brief: Terveystalo Q1 Revenue, Adj. EBITA Beat Expectations
Europe Research Roundup: Air Liquide SA, Cosmo Pharmaceuticals NV, Sulzer AG
Brief: Terveystalo BOD Proposes Dividend Of EUR 0.28 Per Share
Brief: Terveystalo Q4 Revenue Exceeds Consensus Estimates
Brief: Terveystalo Q3 Adjusted EBITA Falls To EUR 12.5 Million
Brief: Terveystalo Gives Profit Warning On Q3 Result
Brief: Terveystalo Acquires Rehabilitation Service Provider Ludus
Brief: Terveystalo Q2 Adjusted EBITA Falls To EUR 24.1 Million
Brief: Terveystalo Appoints Juuso Pajunen As CFO
Brief: Terveystalo To Cancel 1 Mln Treasury Shares Acquired Through Buy-Backs
Brief: Terveystalo Q1 Adjusted EBITA At EUR 38.9 Million
Brief: Terveystalo Acquires Lapin Liikuntaklinikka
Brief: Terveystalo Signs Agreement For EUR 100 Million Domestic Commercial Paper Program
Brief: Terveystalo Completes Share Buyback
Brief: Terveystalo Q3 Profit For Period Falls To EUR 14.5 Mln
Brief: Terveystalo Launches Share Buyback Program
Brief: Terveystalo Board Of Directors Has Resolved On The Distribution Of Dividend
Brief: Terveystalo Q2 Adjusted EBITA Rises To EUR 29.5 Mln
Brief: Terveystalo Owns 97.42% Of Feelgood And Closes Offer For Feelgood